ASCO has recently provided guidance on emerging data on EGFR testing for the purpose of selecting first-line therapy for persons with advanced NSCLC through its Provisional Clinical Opinion.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3092665 | PMC |
| http://dx.doi.org/10.1200/JOP.2010.000166 | DOI Listing |
Publication Analysis
Top Keywords
provisional clinical
8
clinical opinion
8
asco provisional
4
opinion epidermal
4
epidermal growth
4
growth factor
4
factor receptor
4
receptor mutation
4
mutation testing
4
testing practice
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!